NCT01481350View on ClinicalTrials.gov

Sildenafil for Post-capillary Pulmonary Hypertension in Patients Undergoing Cardiac Surgery

PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

February 29, 2012

Primary Completion Date

June 30, 2013

Study Completion Date

December 31, 2013

Conditions
Pulmonary Hypertension
Interventions
DRUG

sildenafil

The patients will receive a dose of 10 mg every 8 hours, for a maximum time of 72 hours.

Trial Locations (1)

10126

San Giovanni Battista Hospital University of Turin, Turin

All Listed Sponsors
lead

University of Turin, Italy

OTHER

NCT01481350 - Sildenafil for Post-capillary Pulmonary Hypertension in Patients Undergoing Cardiac Surgery | Biotech Hunter | Biotech Hunter